A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV

Because vascular occlusion has been observed as a consequence of photodynamic therapy (PDT), this method has been successfully used for the treatment of choroidal neovascularization (CNV) in age-related macular degeneration (AMD). However, most conventional photosensitizers, primarily developed for tumor PDT, lack selectivity for the targeting of neovascularization. An experimental model has been developed for drug screening of new photosensitizers for the treatment of CNV associated with AMD. It consists of intravenous (IV) injection of photosensitizers and fluorescent dyes into the chick's chorioallantoic membrane (CAM), followed by measurement of fluorescence pharmacokinetics, leakage from the vascular system, and photothrombic efficacy.


Published in:
Investigative ophthalmology & visual science, 42, 1, 38-46
Year:
2001
ISSN:
0146-0404
Keywords:
Other identifiers:
Laboratories:




 Record created 2011-02-01, last modified 2018-03-08


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)